Cardiovascular Events During Treatment With Xanthine Oxidoreductase Inhibitors in Patients With Gout and Hyperuricemia in Japan ― A JMDC Claims Database Study ―
Topiroxostat may provide a better tolerated option for the treatment of hyperuricemia and/or gout in Japanese patients with respect to cardiovascular events.
Authors
- Kazuomi Kario
- Hiroshi Kanegae (ORCID: https://orcid.org/0000-0001-5075-3594)
- Seigo Akari (ORCID: https://orcid.org/0000-0001-6641-1062)
Institutions
- Jichi Medical University (JP)
- Genki Plaza Medical Center for Health Care (JP)
- Riso Kagaku (Japan) (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1253/circrep.cr-24-0178
- Citations
- 2
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 2.86